AMG 193 + Other Therapies in Advanced GI & PDAC with homozygous MTAP-deletion (20230223)

AMG 193 + Other Therapies in Advanced GI & PDAC with homozygous MTAP-deletion (20230223)

Es posible que algunos contenidos no estén disponibles en español.

Study Details

Full Title

A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 193 in Combination With other Therapies in Subjects With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous MTAP-deletion Master Protocol (20230223)

Principal Investigator

Niharika
Mettu

Protocol Number

PRO00116091

NCT ID

NCT06360354

Phase

I

Enrollment Status

Open to Enrollment
ClinicalTrials.gov